Trial Information

Summary: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Status: Recruiting

Protocol Number: NV20234

Sponsor: Hoffmann-La Roche

Company Division: Pharmaceutical

Official Scientific Title: A randomized, double-blind trial evaluating conventional and high dose Tamiflu in the treatment of influenza in immunocompromised patients

Brief Summary: This 2 arm study will investigate the efficacy and safety of twice daily conventional and high dose Tamiflu for the treatment of immunocompromised patients (as represented by transplant recipients). Eligible transplant recipients suffering from symptoms of an influenza-like illness will be randomized to receive either conventional dose (30mg-75mg twice daily po, depending on age and weight) or high dose (60mg-150mg twice daily po depending on age and weight) Tamiflu for 10 days. Nasal and throat swabs will be taken, and safety evaluations made, at intervals during the study. The anticipated time on study treatment is <3 months, and the target sample size is 100-500 individuals. Target sample size is 250.

Study Phase: IV

Study Design / Study Details:

• Purpose: Treatment
• Allocation: Randomized
• Masking: Double Blind
• Control: Active
• Assignment: Parallel
• Endpoints: Safety/Efficacy

Study Type:

Condition: Influenza

Intervention Type: Drug

Intervention Name: oseltamivir [Tamiflu]

Primary Outcome: 1. Time to alleviation of all clinical influenza symptoms Time frame: Event driven

Key Secondary Outcomes: 1. Virus shedding and viral load Time frame: Days 1, 2, 6, 8, 11, 15 and 40 2. Time to resolution of fever Time frame: Event driven 3. Development of secondary illnesses, antibiotic use and hospitalizations. Time frame: Event driven 4. AEs, lab parameters, vital signs. Time frame: Throughout study

Inclusion Criteria:

Exclusion Criteria:

Gender: Males or Females

Age Limits: Min: 1 year Years

Accepts Healthy Volunteers: No

Anticipated Start Date: February, 2008

Trial Registration Date: 10/15/2007

Date Last Updated: 04/16/2008

Link To Trial Results

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: May 13, 2008 at 1:58:16 PM